Currently out of the existing stock ratings of Hassan Al-Wakeel, 43 are a BUY (70.49%), 3 are a SELL (4.92%), 15 are a HOLD (24.59%).

Hassan Al-Wakeel

Work Performance Price Targets & Ratings Chart

Analyst Hassan Al-Wakeel, currently employed at BARCLAYS, carries an average stock price target met ratio of 35.92% that have a potential upside of 17.23% achieved within 192 days.

Hassan Al-Wakeel’s has documented 105 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SNN, Smith & Nephew SNATS at 05-Aug-2026.

Wall Street Analyst Hassan Al-Wakeel

Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for SNN (SMITH & NEPHEW SNATS) at 5/31/2022. The price target of $20.72 was fulfilled within 113 days with a profit of $8.6 (29.33%) receiving and performance score of 2.6.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SNN Smith & Nephew SNATS AMFPF Amplifon S.p.A

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Jan-2024

$25.8

$3.55 (15.96%)

1 months 27 days ago
(06-Aug-2026)

1/4 (25%)

$1.7 (7.05%)

98

Hold Since 24-Feb-2021

$26

$2.76 (11.88%)

$30

8 months 28 days ago
(05-Jan-2026)

9/16 (56.25%)

$2.22 (9.34%)

215

Hold Since 31-Jul-2024

1 years 1 months 1 days ago
(02-Sep-2025)

0/2 (0%)

$22.96 (132.03%)

Sell Since 23-Feb-2024

1 years 5 months 11 days ago
(22-Apr-2025)

0/5 (0%)

$24.09 (150.28%)

Hold Since 21-Oct-2021

1 years 7 months 7 days ago
(26-Feb-2025)

0/12 (0%)

$26.43 (171.62%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Hassan Al-Wakeel most bullish on?

Potential upside of $0 has been obtained for SNN (SMITH & NEPHEW SNATS)

What Year was the first public recommendation made by Hassan Al-Wakeel?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?